Effect of niacin therapy on cardiovascular outcomes in patients with coronary artery disease. - Wikidata - awgldk - TriplyDB

Effect of niacin therapy on cardiovascular outcomes in patients with coronary artery disease.

Effect of niacin therapy on cardiovascular outcomes in patients with coronary artery disease.

http://www.wikidata.org/entity/Q33537687

about

Niacin for primary and secondary prevention of cardiovascular events Rice Bran Metabolome Contains Amino Acids, Vitamins & Cofactors, and Phytochemicals with Medicinal and Nutritional Properties.The association of hypertriglyceridemia with cardiovascular events and pancreatitis: a systematic review and meta-analysis.Niacin: the evidence, clinical use, and future directions.Niacin: chemical forms, bioavailability, and health effects.Niacin for primary and secondary prevention of cardiovascular events.The role of extended-release niacin on immune activation and neurocognition in HIV-infected patients treated with antiretroviral therapy - CTN PT006: study protocol for a randomized controlled trial.Treating statin-intolerant patients Targeting high density lipoproteins in the prevention of cardiovascular disease?High density lipoprotein: a therapeutic target in type 2 diabetes.Approach to identifying and managing atherogenic dyslipidemia: a metabolic consequence of obesity and diabetes Safety review of combination drugs for hyperlipidemia.Pharmacologic interactions of multidrug therapy for dyslipidemia.Complementary and alternative medicine therapies for the anesthesiologist and pain practitioner: a narrative review.Effect of niacin on triglyceride-rich lipoprotein apolipoprotein B-48 kinetics in statin-treated patients with type 2 diabetes.The causes and consequences of low levels of high density lipoproteins in patients with diabetes.Nicotinic acid: current status in lipid management and cardiovascular disease prevention.Façons d’identifier et de prendre en charge la dyslipidémie athérogène: Une conséquence métabolique de l’obésité et du diabète.Efficacy and safety evaluation of a large niacin therapeutic interchange program.

P2860

Q24203613-FB044842-1CAA-4C99-9FA6-7AE0176FAA10 Q33752722-17ADDC41-F218-4131-83B0-8A0347A7A7FC Q34215047-755AB5B0-091C-411A-A944-EF6498C137A8 Q34228636-5573E7A1-151F-4BEE-9B25-83CFDBE52BD3 Q34278034-CA8BD56A-D3FD-4E23-845F-132D17256B2B Q34682221-E3DCED5F-4525-4508-A3B0-931D37975251 Q34812071-0E67A323-ED9D-4F89-AE27-DED58B3D26B8 Q35110510-DEBE7A5A-2472-4BE1-9980-EF9813279F7A Q36453173-28118453-48F3-451F-9494-9BC2F8DD995A Q37264429-61821E46-C8D7-4524-ACCB-D5AAFD491245 Q37308578-88A46557-6043-4CAE-8A81-2F7D969875E1 Q37854747-0C87DF64-EC45-4FE6-8754-1C4AB4B41FAC Q38072617-15CACD49-55E6-404E-84B4-865D65FB49D0 Q38607315-4B09E0EE-B010-46E1-8865-9891E27AF2FB Q41041086-67C22C50-80DE-4C5B-BF11-FE4621637457 Q42773416-8DDBD534-AA64-49C8-A521-59B860511B68 Q44548929-8F90EEDF-35A9-421A-B36E-10E964614A35 Q46488015-69917360-157D-449F-BCF1-2728CE2B702B Q48482942-CED30AD7-482B-4501-B7C2-239DF7EEB955

P2860

Effect of niacin therapy on cardiovascular outcomes in patients with coronary artery disease.

http://www.wikidata.org/entity/Q33537687

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Effect of niacin therapy on ca ...... with coronary artery disease.

@ast

Effect of niacin therapy on ca ...... with coronary artery disease.

@en

Effect of niacin therapy on ca ...... with coronary artery disease.

@nl

type

label

Effect of niacin therapy on ca ...... with coronary artery disease.

@ast

Effect of niacin therapy on ca ...... with coronary artery disease.

@en

Effect of niacin therapy on ca ...... with coronary artery disease.

@nl

prefLabel

Effect of niacin therapy on ca ...... with coronary artery disease.

@ast

Effect of niacin therapy on ca ...... with coronary artery disease.

@en

Effect of niacin therapy on ca ...... with coronary artery disease.

@nl

P1433

Q33537687-B0FE2B97-2FE8-46A7-A9A1-C242E1F0DE8B

P1476

Q33537687-B403EC19-10CA-4E07-8270-85181C4ED72F

P2093

Q33537687-0016A6DF-E84B-45E4-B5BF-ED17AB8E990D

Q33537687-16A5446F-681C-4FD1-8F04-F9A03BFB5128

Q33537687-220E6C99-7C13-4F0C-996A-B4210563DD49

Q33537687-4450061C-74F8-49E1-BCEB-7F63BED6F528

Q33537687-624F7196-2A76-4831-B3EF-6F9CAAAF6FDF

Q33537687-802A5D37-EB70-4333-A7E3-D48DA094F87F

Q33537687-9C2877CC-4B30-4C76-80EA-904B14BF2C91

Q33537687-A364BA6C-5B10-458F-BD6D-AC88E78F33AB

Q33537687-ACD61969-CC3C-4178-B1F1-72D2397694BF

Q33537687-C51795BC-D458-4942-AAB0-2E64EEB92FCB

P2860

Q33537687-0757B2CC-26CB-47B7-B7F5-367DE0D51A88

Q33537687-080B5BFF-8347-491E-9982-6C8061C6B915

Q33537687-0F7C75A8-80E8-4EF0-8C82-F3ADFE6DE622

Q33537687-142846C8-91D6-4998-A338-774F6495DD22

Q33537687-2FDC4A85-4EEB-4043-A0C7-4EEA6B73102D

Q33537687-4304DA6A-5ED7-4900-BCB5-8AE3C9242F3F

Q33537687-5470FA3A-80B8-4F37-AF6D-C719620DEB79

Q33537687-5CC2BDBE-9999-4842-A448-3D6D89D60E60

Q33537687-63D7DE91-560B-42E1-8B1C-AF8BF8932905

Q33537687-7D0649D7-6F43-4101-B549-54E4EA3B5A65

P304

Q33537687-763E8B26-11DD-4BAE-B68A-F837976F75CC

P31

Q33537687-1EC8A4C5-E5DE-45C3-8D28-531193E6D264

Q33537687-e262fd94-05f9-4204-b422-35263bc99ce8

P356

Q33537687-220FA3D0-FC8C-4B14-ABB5-BDD4E29A44C2

P433

Q33537687-F2D98445-61C8-4D9D-9DB3-7BED55ABC26D

P478

Q33537687-BDF850D8-8440-4478-B3D7-8F38DBE02B9B

P577

Q33537687-46785C4F-CADD-4143-AC03-FDA5A664F703

P698

Q33537687-2C233420-6B35-4A23-A592-673982A026BD

P921

Q33537687-04093CE7-AB1D-4A0B-BA1E-055624E577DD

P356

1074248410361337

P1433

Journal of Cardiovascular Pharmacology and Therapeutics

P1476

Effect of niacin therapy on ca ...... with coronary artery disease.

@en

P2093

Janos Molnar

http://www.w3.org/2001/XMLSchema#string

Jasleen K Duggal

http://www.w3.org/2001/XMLSchema#string

Mukesh Singh

http://www.w3.org/2001/XMLSchema#string

Navneet Attri

http://www.w3.org/2001/XMLSchema#string

Neyaz Ahmed

http://www.w3.org/2001/XMLSchema#string

Param P Singh

http://www.w3.org/2001/XMLSchema#string

Rohit Arora

http://www.w3.org/2001/XMLSchema#string

Sandeep Khosla

http://www.w3.org/2001/XMLSchema#string

Sarabjeet Singh

http://www.w3.org/2001/XMLSchema#string

Suneet Pahwa

http://www.w3.org/2001/XMLSchema#string

P2860

Measuring inconsistency in meta-analyses

Quantifying heterogeneity in a meta-analysis

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin.

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.

Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.

Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial.

Extended-release niacin or ezetimibe and carotid intima-media thickness.

Low HDL-C: a secondary target of dyslipidemia therapy.

Combined statin and niacin therapy remodels the high-density lipoprotein proteome.

P304

158-166

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1074248410361337

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20208032

http://www.w3.org/2001/XMLSchema#string

P921

Aparato circulatorio